Literature DB >> 2687921

Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs.

S R McGurk1, E D Levin, L L Butcher.   

Abstract

Performance on the radial-arm maze depends on the integrity of both cholinergic and dopaminergic systems. We have previously found that administration of either the nicotinic-cholinergic antagonist, mecamylamine, or the muscarinic-cholinergic antagonist, scopolamine, impairs choice accuracy in the radial-arm maze. Co-administration of the dopaminergic antagonist, haloperidol, ameliorated the performance deficit caused by scopolamine but exacerbated the deficit caused by mecamylamine. Furthermore, antagonism of the effect of scopolamine is due specifically to blockade of D1 receptors. In the present experiment behaviorally subthreshold doses of mecamylamine and the D2 antagonist raclopride impaired maze performance when administered together. No interactive effects were observed between mecamylamine and the D1 antagonist SCH 23390. Although several of the drug treatments studied significantly increased choice latency, an index of motor behavior, there was no perfect relationship between choice accuracy and choice latency. These data indicate that nicotinic-cholinergic and muscarinic-cholinergic systems interact selectively and differentially with D1 and D2 dopaminergic systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2687921     DOI: 10.1007/bf00445560

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats.

Authors:  E D Levin; M Castonguay; G D Ellison
Journal:  Behav Neural Biol       Date:  1987-09

3.  Cholinergic-dopaminergic interactions in radial-arm maze performance.

Authors:  S R McGurk; E D Levin; L L Butcher
Journal:  Behav Neural Biol       Date:  1988-03

4.  Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats.

Authors:  E D Levin
Journal:  Behav Neural Biol       Date:  1988-09

Review 5.  Psychopharmacological effects in the radial-arm maze.

Authors:  E D Levin
Journal:  Neurosci Biobehav Rev       Date:  1988       Impact factor: 8.989

Review 6.  D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.

Authors:  D Clark; F J White
Journal:  Synapse       Date:  1987       Impact factor: 2.562

7.  Spatial working memory in rats: effects of monoaminergic antagonists.

Authors:  W W Beatty; J R Rush
Journal:  Pharmacol Biochem Behav       Date:  1983-01       Impact factor: 3.533

8.  Chronic haloperidol effects on oral movements and radial-arm maze performance in rats.

Authors:  E D Levin; D M Galen; G D Ellison
Journal:  Pharmacol Biochem Behav       Date:  1987-01       Impact factor: 3.533

9.  Effects of scopolamine, pentobarbital, and amphetamine on radial arm maze performance in the rat.

Authors:  D A Eckerman; W A Gordon; J D Edwards; R C MacPhail; M I Gage
Journal:  Pharmacol Biochem Behav       Date:  1980-04       Impact factor: 3.533

  9 in total
  11 in total

1.  Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors.

Authors:  M Zoli; M R Picciotto; R Ferrari; D Cocchi; J P Changeux
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

2.  Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs.

Authors:  E D Levin; P Kim; R Meray
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

3.  Dopamine D2 receptor plays a role in memory function: implications of dopamine-acetylcholine interaction in the ventral hippocampus.

Authors:  Hiroshige Fujishiro; Hiroyuki Umegaki; Yusuke Suzuki; Shinobu Oohara-Kurotani; Yoko Yamaguchi; Akihisa Iguchi
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 4.  Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.

Authors:  Edward D Levin; F Joseph McClernon; Amir H Rezvani
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

5.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats.

Authors:  J B Acri; D E Morse; E J Popke; N E Grunberg
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

7.  Effects of chronic nicotine and haloperidol administration on muscarinic receptor-mediated phosphoinositide turnover in rat brain slices.

Authors:  R Li; L L Wing; D G Kirch; R J Wyatt; D M Chuang
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation.

Authors:  Nibaldo C Inestrosa; Juan A Godoy; Jessica Y Vargas; Macarena S Arrazola; Juvenal A Rios; Francisco J Carvajal; Felipe G Serrano; Ginny G Farias
Journal:  Neuromolecular Med       Date:  2013-07-11       Impact factor: 3.843

9.  Cholinergic connectivity: it's implications for psychiatric disorders.

Authors:  Elizabeth Scarr; Andrew S Gibbons; Jaclyn Neo; Madhara Udawela; Brian Dean
Journal:  Front Cell Neurosci       Date:  2013-05-03       Impact factor: 5.505

10.  DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory.

Authors:  Annabella Di Giorgio; Ryan M Smith; Leonardo Fazio; Enrico D'Ambrosio; Barbara Gelao; Aldo Tomasicchio; Pierluigi Selvaggi; Paolo Taurisano; Tiziana Quarto; Rita Masellis; Antonio Rampino; Grazia Caforio; Teresa Popolizio; Giuseppe Blasi; Wolfgang Sadee; Alessandro Bertolino
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.